Skip to main content
Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance.
- Author(s): Lienhardt, Christian;
- Vernon, Andrew A;
- Cavaleri, Marco;
- Nambiar, Sumati;
- Nahid, Payam
- et al.
Published Web Locationhttps://doi.org/10.1371/journal.pmed.1002915
Christian Lienhardt and colleagues discuss the importance of communication and coordination between regulators, researchers, and policy makers to ensure tuberculosis trials provide high-quality evidence for policy decisions.
For improved accessibility of PDF content, download the file to your device.